Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 5;16(3):e0243682. doi: 10.1371/journal.pone.0243682

Comparison of porcine corneal decellularization methods and importance of preserving corneal limbus through decellularization

Abdulkadir Isidan 1, Shaohui Liu 2, Angela M Chen 1, Wenjun Zhang 1, Ping Li 1, Lester J Smith 3,4, Hidetaka Hara 5, David K C Cooper 5, Burcin Ekser 1,*
Editor: Alexander V Ljubimov6
PMCID: PMC7935270  PMID: 33667231

Abstract

Background

The aim of this study is to compare the three previously applied, conventional porcine corneal decellularization methods and to demonstrate the importance of preserving the corneal limbus through decellularization.

Methods

Fresh, wild-type (with or without) limbus porcine corneas were decellularized using three different methods, including (i) sodium dodecyl sulfate (SDS), (ii) hypertonic saline (HS), and (iii) N2 gas (NG). Post-treatment evaluation was carried out using histological, residual nuclear material, and ultrastructural analyses. Glycerol was used to help reduce the adverse effects of decellularization. The corneas were preserved for two weeks in cornea storage medium.

Results

All three decellularization methods reduced the number of keratocytes at different rates in the stromal tissue. However, all methods, except SDS, resulted in the retention of large numbers of cells and cell fragments. The SDS method (0.1% SDS, 48h) resulted in almost 100% decellularization in corneas without limbus. Low decellularization capacity of the NG method (<50%) could make it unfavorable. Although HS method had a more balanced damage-decellularization ratio, its decellularization capacity was lower than SDS method. Preservation of the corneoscleral limbus could partially prevent structural damage and edema, but it would reduce the decellularization capacity.

Conclusion

Our results suggest that SDS is a very powerful decellularization method, but it damages the cornea irreversibly. Preserving the corneoscleral limbus reduces the efficiency of decellularization, but also reduces the damage.

1. Introduction

It is estimated that there are 36 million people worldwide who are blind [1]. Of these patients, corneal blindness accounts for 5–12% of all the cases [24]. Furthermore, due to corneal trauma and ulcers, 1.5–2.0 million new individuals lose sight in one eye every year [5]. Currently, corneal allo-transplantation is the only approved curative option when the cornea becomes opaque [6]. Unfortunately, there is a large discrepancy between the supply and demand of corneal tissue in many countries. In a broad perspective, there are four ways that could alleviate the cornea shortage worldwide: 1) prevention; 2) development of strategies for corneal healing; 3) enhancing the organ donation numbers; and 4) development of tissue grafts that mimic the cornea. Although a decreasing trend was observed in the last decades with the action plans of the World Health Organization, preventable causes of corneal blindness (e.g. trachoma, onchocerciasis, keratomalacia) still account for approximately 80% of all corneal blindness [1, 4, 7].

Currently, deceased human donors are the only source for corneal grafts, but the numbers are far away from supplying the demand. Recently, tissue engineering strategies have emerged that could solve the corneal shortage. 3D-bioprinting and xenotransplantation (e.g., pig cornea-to-human) are two major strategies that have potential to solve the corneal shortage. While the heterogeneic architecture of the cornea could be a problem for 3D-bioprinting, conservation of the extracellular matrix (ECM) proteins and mechanical properties are a most significant advantage for corneal xenotransplantation [8]. The availability and ability of genetic engineering of the donor pig to address the immunological target make xenotransplantation more attractive [9]. However, immune rejection still remains to be overcome despite the use of genetically-engineered pig corneas, cells, and/or biomaterials. Although decellularization techniques aim to avoid this immune reaction, the problem with a decellularization strategy is that almost all techniques have variable adverse effects on the corneal tissue.

In the past, many different decellularization protocols for porcine corneal tissues have been reported using biological, physical, and chemical compounds [1012]. Besides conventional methods there are newer methods such as high hydrostatic pressure, supercritical CO2, phospholipase A2, formic acid etc. and newer agents that used to improve conventional methods such as benzonase, sodium N-lauroyl glutamate, supernuclease etc. [1318]. An ideal corneal decellularization method should have high cell removal and antigenicity elimination capacities, while maintaining the native histo-architecture and ECM. In the present study, we evaluated and compared side-by-side three conventional decellularization protocols of full thickness pig corneas with or without the limbus in order to assess decellularization efficiency and undesirable effects of each decellularization protocol as well as the importance of preserving the corneal limbus.

2. Materials and methods

2.1. Decellularization protocols

Fresh, wild-type (WT) porcine eyeballs were purchased from a local slaughterhouse. Eyeballs were enucleated within 1 hour after death and transported with 1% Antibiotic-Antimycotic in Dulbecco’s phosphate-buffered saline (DPBS). The corneas were excised either with at least 1 mm of scleral tissue (cornea w/ limbus) or at least 1 mm within the corneal limbus (cornea w/o limbus) (Fig 1). All corneas were then rinsed with 10% Antibiotic-Antimycotic solution for 15 minutes. Full-thickness WT native porcine corneas (NPCs) were used in these experiments. NPCs were divided into four groups (n = 6 in each group; 3 with limbus and 3 without limbus), and decellularization protocols were performed as follows: 1) Untreated NPCs (control group). 2) SDS (Sodium Dodecyl Sulfate) Method: corneas were immersed in 0.1% SDS (GibcoBrl, Grand Island, NY) for 48 hours at room temperature with 300 rpm of continuous shaking and decellularization solution renewed every 12 hours [19]. 3) HS (Hypertonic Saline) Method: corneas were immersed in ultrapure water for 12 hours and subsequently treated with 2 M NaCl HS (Sigma-Aldrich, St. Louis, MO) for 30 min, followed by ultrapure water again for 30 min. This cycle was repeated 3 times. Afterwards, corneas were agitated with 0.2% Triton X-100 (TX; Sigma, St. Louis, MO) for 6 hours [20]; 4) NG (Nitrogen Gas) Method: corneas were placed in a 50 ml Falcon tube. Liquid nitrogen was poured into the tubes, closed tightly and parafilmed. NG filled, hypoxic, tubes were kept at room temperature for one week [21]. All corneas were washed with transport solution for 10 minutes, 3 times after decellularization.

Fig 1. A figuration of a corneal graft with limbus or without the limbus.

Fig 1

Additionally, in order to show the capacity of glycerol to restore transparency in the different methods, three decellularized corneas from each study group were agitated with glycerol (RPI, Mt. Prospect, IL) for two hours.

2.2. Characterization

2.2.1. Macroscopic assessments

Transparency of decellularized corneas was assessed visually, and the severity of edema was measured using tissue sections. Because of the heterogeneity of the edema, tissue thickness was measured at the shortest and longest places of each cornea. Median sections were used in every assessment.

2.2.2. Histological analysis

Hematoxylin-eosin (H&E) staining was performed to evaluate histo-architectural properties of the decellularized corneas. Briefly, corneal samples were fixed in 10% (v/v) neutral buffered formalin for 24h at room temperature, dehydrated, and embedded in paraffin wax. Sections (5μm) were cut and stained with H&E. Afterwards, the sections were analyzed using a light microscope (Leica DMI1, Wetzlar, Germany).

2.2.3. Nucleic acid analysis

Hoechst 33342 staining was performed on 5μm tissue sections to evaluate residual nuclear materials. The sections were then observed using a florescence microscope (Leica DMI8, Wetzlar Germany). The number of stained particles was counted by image analysis software (ImageJ, Bethesda, MD) in three identical-sized (0.25 mm2) areas of each corneal stroma.

2.2.4. Ultrastructural analysis

Transmission electron microscopy (TEM) imaging was performed to evaluate ultrastructural properties of decellularized corneas. Corneas were fixed with 3% glutaraldehyde in 0.1M phosphate buffer and 80-90nm sections were cut and then viewed on a Tecnai Spirit (Thermo Fisher, Hillsboro, OR) with digital images taken via a charge-coupled device camera (Advanced Microscopy Techniques, Danvers, MA). The average collagen fibril diameters and spacing of the selected electron micrographs were also measured by ImageJ.

2.2.5. Expression of results and statistical analysis

All data were expressed as the mean ± SD. Independent samples t test and one-way ANOVA were used to compare mean values. A p value of <0.05 was considered as statistically significant. All analyses were performed with commercial software (GraphPad Prism8, San Diego, CA, USA).

3. Results

3.1. Macroscopic assessments

Although all 3 methods caused edema, SDS caused significantly more edema compared to HS and NG, especially when the limbus was preserved. However, HS caused slightly more edema in corneas without the limbus (Fig 2). The average thickness of the corneas after decellularization increased in all methods in both groups, varying between 20% to 273% (Table 1) compared to untreated corneas, which was 1.15 ± 0.04 mm. NG w/ limbus and SDS w/ limbus groups were able to return to baseline thickness after 2 hours of glycerol treatment, while the other groups were still significantly thicker than the native cornea. Visually, all the methods considerably reduced the transparency. All the groups regained transparency with 2 hours of glycerol treatment, except the SDS w/o limbus group (Fig 2). Since epithelial removal is important for re-epithelialization after transplantation [22], we have further evaluated all corneas with or without limbus in all three decellularization methods and found that epithelial removal was successful in all groups (Fig 3).

Fig 2. Macroscopic and microscopic assessments of decellularized and glycerol- treated pig corneas with or without limbus.

Fig 2

HS = Hypertonic saline; H&E = Hematoxylin and eosin; NG = Nitrogen gas; SDS = Sodium dodecyl sulfate; TEM = Transmission electron microscopy; WT-NPC = Wild-type native porcine cornea; w/ = with w/o = without.

Table 1. Average thickness of wild-type porcine corneas after decellularization, after glycerol treatment, and after preservation.

After decellularization After 2 hours of glycerol treatment
p (Decellularized vs WT-NPC) p (Decellularized vs glycerol treated) p (Glycerol treated vs WT-NPC)
SDS w/ limbus 3.62 ± 0.18 1.05 ± 0.09
<0.0001 <0.0001 0.0524
HS w/ limbus 1.83 ± 0.14 1.44 ± 0.10
0.0009 0.0007 0.0002
NG w/ limbus 1.33 ± 0.06 1.16 ± 0.06
0.0039 0.0018 0.7287
SDS w/o limbus 4.15 ± 0.22 1.92 ± 0.22
<0.0001 <0.0001 <0.0001
HS w/o limbus 4.29 ± 0.31 1.76 ± 0.14
<0.0001 <0.0001 <0.0001
NG w/o limbus 1.64 ± 0.11 1.33 ± 0.06
0.0033 0.0004 0.0003
WT—NPC 1.15 ± 0.04

All results were expressed as the mean ± SD (millimeter). HS = Hypertonic saline; NG = Nitrogen gas; SDS = Sodium dodecyl sulfate; SD = Standard deviation; WT-NPC = Wild-type native porcine cornea; w/ = with; w/o = without.

Fig 3. H&E sections of outermost layers of treated and untreated corneas.

Fig 3

HS = Hypertonic saline; H&E = Hematoxylin and eosin; NG = Nitrogen gas; SDS = Sodium dodecyl sulfate; WT-NPC = Wild-type native porcine cornea; w/ = with w/o = without.

3.2. Histological examination

WT-NPCs contain a typical lamellar structure as seen in the human cornea, in which the epithelium, Bowman’s layer, stroma, Descemet’s membrane, and endothelium are all displayed [11]. When treated with SDS, histological examination showed that remarkable numbers of cells were removed inform the corneas, as demonstrated in H&E and Hoechst staining. However, many keratocytes were present in HS and NG groups (Fig 2). In the NG group, besides the existence of a large number of cells, even the layers of the cornea were distinguishable.

3.3. Nucleic acid analysis

Results of Hoechst staining were mostly consistent with the results of H&E staining. All decellularization methods reduced nuclear components compared to controls (p<0.0001). Fig 2 shows a representative image from each group. The average of counted nucleic acid particles in a 0.25 mm2 area of the corneal stroma is shown in Table 2. SDS was the strongest agent on the removal of nucleic acids, eliminating approximately 94.3% of nucleic acid in corneas w/ limbus and %100 of nucleic acid in corneas w/o limbus. Although there was a distinct decrease in the amount of nucleic acid detected in HS and NG, a significant amount remained in both groups (Table 2).

Table 2. Average number of counted nucleic acid particles in different groups and comparisons.

With Limbus p (with limbus vs WT—NPC) Without Limbus p (without limbus vs WT—NPC)
WT-NPC 162.50 ± 6.68
SDS 9.25 ± 2.10 (p<0.0001) 0 (p<0.0001)
HS 32.25 ± 3.38 (p<0.0001) 41.25 ± 4.05 (p<0.0001)
NG 87.50 ± 7.24 (p<0.0001) 86.25 ± 3.66 (p<0.0001)

All results were expressed as the mean ± SD. HS = Hypertonic saline; NG = Nitrogen gas; SD = Standard deviation; SDS = Sodium dodecyl sulfate; WT-NPC = Wild-type native porcine cornea; w/ = with; w/o = without.

3.4. Ultrastructural examination

While WT-NPCs had an extremely ordered, stacked collagen fibrillary arrangement, all of the decellularized corneas were changed (Fig 2). Collagen fibril diameters were shown to have significant change between the different groups (Table 3). However, a loss of collagen fibrils, a parallel loss of lamellar structure, and an increase of collagen fibril spacing were observed in all groups (Table 3). SDS disrupted the ultrastructure of the cornea most severely, resulting in disorganization of fibrils, and therefore increased spacing between the fibrils in corneas both with and without limbus.

Table 3. Results of the ultrastructural analysis.

Collagen fibril diameter Collagen fibril spacing
w/ limbus, p (w/ limbus vs WT—NPC) w/o limbus, p (w/o limbus vs WT—NPC) w/ limbus, p (w/ limbus vs WT—NPC) w/o limbus, p (w/o limbus vs WT—NPC)
SDS 32.30 ± 1.09 (p = 0.5840) 31.38 ± 2.77 (p = 0.9678) 132.64 ± 10.61 (p<0.0001) 169.09 ± 13.47 (p<0.0001)
HS 31.25 ± 1.04 (p = 0.9073) 30.98 ± 2.78 (p = 0.7467) 69.07 ± 5.81 (p<0.0001) 121.31 ± 6.75 (p<0.0001)
NG 31.63 ± 3.15 (p = 0.8957) 31.60 ± 3.03 (p = 0.9082) 38.33 ± 5.82 (p = 0.0343) 43.62 ± 3.79 (p = 0.0002)
WT-NPC 31.43 ± 3.12 31.27 ± 7.19

All results were expressed as the mean ± SD (nanometer). HS = Hypertonic saline; NG = Nitrogen gas; SD = Standard deviation; SDS = Sodium dodecyl sulfate; WT-NPC = Wild-type native porcine cornea; w/ = with; w/o = without.

4. Discussion

The conservation of the ECM proteins of the cornea across species favors xenotransplantation over synthetic materials. This advantage makes natural material more suitable for cell attachment, migration, and proliferation. Furthermore, natural material already has the desired shape, transparency and mechanical properties. However, as in other xenotransplantation studies (e.g. liver, heart, kidney), the expression of xenoantigens remains one of the most challenging problems, having the potential to initiate inflammation, rejection, and tissue destruction [23]. Hypothetically, removal of cellular properties from the tissue would reduce the load of antigenicity. In our early studies, we used decellularized full-thickness WT pig corneas and perfused them continuously in a special bioreactor with human serum and peripheral blood mononuclear cells for one week to assess the human immune response to pig corneas which were decellularized by different methods [24]. Although the study was limited, we demonstrated that the HS method resulted in less antibody binding and more biocompatibility, indicating the importance of reducing antigenicity [24].

For the purpose of reducing cellular components and therefore antigenicity, many different decellularization techniques have been utilized to obtain an acellular corneal matrix [11, 21, 25]. The eventual goal of decellularization techniques is to completely remove all cellular components and nuclear materials. Crapo et al. have suggested that it is impossible to remove 100% of cellular material by decellularization techniques. Thus, Crapo et al. have defined the term of “sufficient decellularization” by suggesting minimal criteria, including: (i) ECM should contain <50ng dsDNA per mg dry weight, (ii) DNA fragments should be shorter than 200 bp, and (iii) there should be no visible nuclear component within the ECM [26].

Although these conditions only pertain to cellular and nuclear components, the antigenicity of the cornea is also important. The expression of xenoantigens (e.g., galactose-α1,3-galactose, N-glycolylneuraminic acid) in the cornea is well-known [27]. Lee et al. have previously shown that the reduced antigenicity in decellularized corneas might prolong the survival of the graft [28].

Since the decellularization process removes the endothelium, the efficacy of decellularized grafts is limited to lamellar keratoplasty, unless it is re-endothelialized with human corneal endothelial cells, which currently is challenging [29]. Zhang et al. performed lamellar keratoplasty in 37 patients with fungal keratitis using porcine corneal grafts that were decellularized by the HS method [20]. Neither rejection nor complication was detected in 3-years post-decellularization follow-up. Recently, Shi et al. reported the results of a clinical study indicating the safety of acellular porcine corneas in lamellar keratoplasty for bacterial, fungal, and unknown keratitis [30]. The group used a high hydrostatic pressure-based method to accomplish the decellularization. In the 24-month follow-up, 22 out of 23 grafts survived. Both studies showed promising applications of using acellular porcine corneas in clinical applications, especially in patients who have healthy endothelium and posterior stroma structures. On the other hand, Choi et al. defined the protocol to perform the first clinical trial of penetrating keratoplasty in two patients, by using native porcine corneas with a determined immunosuppressant regimen [31].

In the current study, we used three conventional decellularization methods, demonstrating undesired effects and efficiency of each method, with special attention to the effect of retaining the corneoscleral limbus. SDS, HS, and NG methods were selected for this study because of successful previous reports [1921]. Among these methods, HS is the only technique which has been employed in a clinical trial [21]. Our results indicated that, although HS had less undesired effects on corneal structure, its decellularization capacity was much lower than SDS. Luo et al. has obtained acellular and ultrastructurally proper corneas using the HS method [32]. Similarly, our results were not consistent with the previous report on the NG method, which pointed out that NG was a promising agent with an ability to decellularize porcine cornea entirely [21]. Many internal (presence of corneoscleral limbus, species of the pig) and external (temperature, ratio of cornea to solution, duration time, concentration of agent, etc.) factors could affect the efficiency of decellularization.

After obtaining a decellularized porcine corneal matrix, the ultimate goal is to recellularize it with human cells. Several different cell types (adipose stem cells, induced pluripotent stem cells, keratocytes, endothelial cells, embryonic stem cells) and various recellularization techniques (seeding, injection) have been used for repopulation of human corneal cells [3336]. Previously, SDS, HS, and NG based methods created a decellularized cornea that is suitable for recellularization [21, 33, 36]. Future studies will focus on the effect of preserving limbus on recellularization.

4.1. Importance of corneoscleral limbus

The corneoscleral limbus is an immunologic and physical barrier between the sclera and cornea [37]. Limbal palisades of Vogt also help to support the unique and richly-vascularized structure of the corneoscleral limbus [38]. The differences between decellularization methods of pig corneas with or without limbus have been summarized in Table 4. According to our results, ultrastructural parameters including thickness after decellularization, thickness after glycerol treatment, and collagen fibril spacing were significantly different between the groups with and without limbus, favoring the group with limbus. However, another structural parameter, collagen fibril diameter, did not show statistically significant change despite the preservation of limbus (Table 3). The decellularization parameter, amount of nucleic acid, was significantly different in the group without limbus in SDS- and HS-based methods but not in NG-based method. Our results indicate that preserving the corneoscleral limbus partially prevented structural damage and edema but would reduce the decellularization capacity (except NG). These differences may originate from the unique structure of the corneoscleral limbus that partly prevents decellularization agents to permeate into the tissue. Ultrastructural and histo-architectural properties are very important to the reversibility of natural corneal properties. However, the extent of decellularization is important to reduce antigenicity as well. Whether preserving the corneoscleral limbus presents a dilemma between greater decellularization and better ultrastructure needs to be further investigated.

Table 4. Comparison of mean values of decellularized corneas with limbus vs without limbus.

SDS HS NG
Thickness after decellularization (from Table 1) p = 0.0022 p<0.0001 p = 0.0004
Thickness after 2 hours glycerol treatment (from Table 1) p<0.0001 p = 0.0024 p = 0.0086
Amount of nucleic acid (from Table 2) p<0.0001 p = 0.0005 p = 0.6900
Collagen fibril diameter (from Table 3) p = 0.5402 p = 0.8486 p = 0.9855
Collagen fibril spacing (from Table 3) p<0.0001 p<0.0001 p = 0.0349

HS = Hypertonic saline; NG = Nitrogen gas; SD = Standard deviation; SDS = Sodium dodecyl sulfate. Results that written bold are in favor of with limbus group, italic are in favor of without limbus group. More decellularization and better preservation of corneal structure considered as favorable. (In this table each p value represents the comparison of the mean values of decellularized corneas with limbus vs without limbus in respected parameter and method. For example, in the first box, p = 0.0022 represents the comparison of thickness after decellularization between SDS with limbus and SDS without limbus group).

5. Conclusion

Our findings demonstrated that, among the decellularization methods that were employed, the SDS method in pig corneas without limbus was preferred for its ability to achieve approximately 100% decellularization. Unfortunately, this agent harmed the cornea irreversibly, rendering its clinical use questionable. Although the NG-based method was not associated with important damage to the corneal ultrastructure, its low decellularization capacity (<50%) made it unfavorable. The HS method had a more balanced damage-decellularization ratio, but its decellularization capacity was lower than the SDS method. Future clinical trials should investigate (i) the human immune response against decellularized porcine corneas in a more detailed way, and (ii) the long-term physical and biological properties of xeno-transplanted porcine corneas.

Supporting information

S1 Data

(XLSX)

S2 Data

(XLSX)

S3 Data

(XLSX)

S4 Data

(XLSX)

S5 Data

(XLSX)

Abbreviations

DPBS

Dulbecco’s phosphate-buffered saline

ECM

Extracellular matrix

H&E

Hematoxylin-eosin

HS

Hypertonic saline

NG

N2 gas

NPCs

Native porcine corneas

SD

Standard deviation

SDS

Sodium dodecyl sulfate

TEM

Transmission electron microscopy

TX

Triton X-100

WT

Wild-type

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

Work on xenotransplantation in the Xenotransplantation Research Laboratory at Indiana University has been supported by internal funds of the Department of Surgery, in part, with support by the Board of Directors of the Indiana University Health Values Fund for Research Award (VFR-457-Ekser), the Indiana Clinical and Translational Sciences Institute, funded in part by Grant #UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organization. Global initiative for the elimination of avoidable blindness: action plan 2006–2011. 2007. https://www.who.int/blindness/Vision2020_report.pdf Accessed 30 June 2020.
  • 2.Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888–e897. 10.1016/S2214-109X(17)30293-0 [DOI] [PubMed] [Google Scholar]
  • 3.Lamm V, Hara H, Mammen A, Dhaliwal D, Cooper DK. Corneal blindness and xenotransplantation. Xenotransplantation. 2014;21(2):99–114. 10.1111/xen.12082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Oliva MS, Schottman T, Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol. 2012;60(5):423–427. 10.4103/0301-4738.100540 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79(3):214–221. [PMC free article] [PubMed] [Google Scholar]
  • 6.Shi Y, Bikkuzin T, Song Z, Jin X, Jin H, Li X, et al. Comprehensive evaluation of decellularized porcine corneal after clinical transplantation. Xenotransplantation. 2017;24(6). 10.1111/xen.12338 [DOI] [PubMed] [Google Scholar]
  • 7.World Health Organization. Action plan for the prevention of avoidable blindness and visual impairment 2009–2013. 2010. https://www.who.int/blindness/ACTION_PLAN_WHA62-1-English.pdf Accessed 30 June 2020.
  • 8.Li N, Wang X, Wan P, Huang M, Wu Z, Liang X, et al. Tectonic lamellar keratoplasty with acellular corneal stroma in high-risk corneal transplantation. Mol Vis. 2011;17:1909–1917. [PMC free article] [PubMed] [Google Scholar]
  • 9.Ekser B, Ezzelarab M, Hara H, van der Windt DJ, Wijkstrom M, Bottino R, et al. Clinical xenotransplantation: the next medical revolution? Lancet. 2012;379(9816):672–683. 10.1016/S0140-6736(11)61091-X [DOI] [PubMed] [Google Scholar]
  • 10.Lynch AP, Ahearne M. Strategies for developing decellularized corneal scaffolds. Exp Eye Res. 2013;108:42–47. 10.1016/j.exer.2012.12.012 [DOI] [PubMed] [Google Scholar]
  • 11.Isidan A, Liu S, Li P, Lashmet M, Smith LJ, Hara H, et al. Decellularization methods for developing porcine corneal xenografts and future perspectives. Xenotransplantation. 2019;26(6):e12564. 10.1111/xen.12564 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mendibil U, Ruiz-Hernandez R, Retegi-Carrion S, Garcia-Urquia N, Olalde-Graells B, Abarrategi A. Tissue-Specific Decellularization Methods: Rationale and Strategies to Achieve Regenerative Compounds. Int J Mol Sci. 2020;21(15):5447. 10.3390/ijms21155447 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sasaki S, Funamoto S, Hashimoto Y, Kimura T, Honda T, Hattori S, et al. In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas. Mol Vis. 2009;15:2022–2028. [PMC free article] [PubMed] [Google Scholar]
  • 14.Topuz B, Günal G, Guler S, Aydin HM. Use of supercritical CO2 in soft tissue decellularization. Methods Cell Biol. 2020;157:49–79. 10.1016/bs.mcb.2019.10.012 [DOI] [PubMed] [Google Scholar]
  • 15.Wu Z, Zhou Y, Li N, Huang M, Duan H, Ge J, et al. The use of phospholipase A(2) to prepare acellular porcine corneal stroma as a tissue engineering scaffold. Biomaterials. 2009;30(21):3513–22. 10.1016/j.biomaterials.2009.03.003 [DOI] [PubMed] [Google Scholar]
  • 16.Lin HJ, Wang TJ, Li TW, Chang YY, Sheu MT, Huang YY, et al. Development of Decellularized Cornea by Organic Acid Treatment for Corneal Regeneration. Tissue Eng Part A. 2019;25(7–8):652–662. 10.1089/ten.TEA.2018.0162 [DOI] [PubMed] [Google Scholar]
  • 17.Liu J, Li Z, Li J, Liu Z. Application of benzonase in preparation of decellularized lamellar porcine corneal stroma for lamellar keratoplasty. J Biomed Mater Res A. 2019;107(11):2547–2555. 10.1002/jbm.a.36760 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Dong M, Zhao L, Wang F, Hu X, Li H, Liu T, et al. Rapid porcine corneal decellularization through the use of sodium N-lauroyl glutamate and supernuclease. J Tissue Eng. 2019;10:2041731419875876. 10.1177/2041731419875876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.González-Andrades M, Carriel V, Rivera-Izquierdo M, Garzón I, González-Andrades E, Medialdea S, et al. Effects of Detergent-Based Protocols on Decellularization of Corneas With Sclerocorneal Limbus. Evaluation of Regional Differences. Transl Vis Sci Technol. 2015;4(2):13. 10.1167/tvst.4.2.13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zhang MC, Liu X, Jin Y, Jiang DL, Wei XS, Xie HT. Lamellar keratoplasty treatment of fungal corneal ulcers with acellular porcine corneal stroma. Am J Transplant. 2015;15(4):1068–1075. 10.1111/ajt.13096 [DOI] [PubMed] [Google Scholar]
  • 21.Amano S, Shimomura N, Yokoo S, Araki-Sasaki K, Yamagami S. Decellularizing corneal stroma using N2 gas. Mol Vis. 2008;14:878–882. [PMC free article] [PubMed] [Google Scholar]
  • 22.Shafiq MA, Gemeinhart RA, Yue BY, Djalilian AR. Decellularized human cornea for reconstructing the corneal epithelium and anterior stroma. Tissue Eng Part C Methods. 2012;18(5):340–8. 10.1089/ten.TEC.2011.0072 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wolf E, Kemter E, Klymiuk N, Reichart B. Genetically modified pigs as donors of cells, tissues, and organs for xenotransplantation. Anim Front. 2019;9(3):13–20. 10.1093/af/vfz014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Isidan A, Smith LJ, Naqvi RA, Chen AM, Liu S, Li P, et al. Investigation of the human immune response to porcine corneal xenografts using a bioreactor perfusion system. Xenotransplantation. 2019;26(5):e12553. [Google Scholar]
  • 25.Hashimoto Y, Funamoto S, Sasaki S, Honda T, Hattori S, Nam K, et al. Preparation and characterization of decellularized cornea using high-hydrostatic pressurization for corneal tissue engineering. Biomaterials. 2010;31(14):3941–3948. 10.1016/j.biomaterials.2010.01.122 [DOI] [PubMed] [Google Scholar]
  • 26.Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials. 2011;32(12):3233–3243. 10.1016/j.biomaterials.2011.01.057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cohen D, Miyagawa Y, Mehra R, Lee W, Isse K, Long C, et al. Distribution of non-gal antigens in pig cornea: relevance to corneal xenotransplantation. Cornea. 2014;33(4):390–397. 10.1097/ICO.0000000000000069 [DOI] [PubMed] [Google Scholar]
  • 28.Lee W, Miyagawa Y, Long C, Cooper DK, Hara H. A comparison of three methods of decellularization of pig corneas to reduce immunogenicity. Int J Ophthalmol. 2014;7(4):587–593. 10.3980/j.issn.2222-3959.2014.04.01 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Liu Y, Sun H, Hu M, Zhu M, Tighe S, Chen S, et al. Human Corneal Endothelial Cells Expanded In Vitro Are a Powerful Resource for Tissue Engineering. Int J Med Sci. 2017;14(2):128–135. 10.7150/ijms.17624 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Shi W, Zhou Q, Gao H, Li S, Dong M, Wang T, et al. Protectively decellularized porcine cornea versus human donor cornea for lamellar transplantation. Adv Funct Mater. 2019;29:1902491. [Google Scholar]
  • 31.Choi HJ, Yoon CH, Hyon JY, Lee HK, Song JS, Chung TY, et al. Protocol for the first clinical trial to investigate safety and efficacy of corneal xenotransplantation in patients with corneal opacity, corneal perforation, or impending corneal perforation. Xenotransplantation. 2019;26(1):e12446. 10.1111/xen.12446 [DOI] [PubMed] [Google Scholar]
  • 32.Luo H, Lu Y, Wu T, Zhang M, Zhang Y, Jin Y. Construction of tissue-engineered cornea composed of amniotic epithelial cells and acellular porcine cornea for treating corneal alkali burn. Biomaterials. 2013;34(28):6748–6759. 10.1016/j.biomaterials.2013.05.045 [DOI] [PubMed] [Google Scholar]
  • 33.Alio del Barrio JL, Chiesa M, Garagorri N, Garcia-Urquia N, Fernandez-Delgado J, Bataille L, et al. Acellular human corneal matrix sheets seeded with human adipose-derived mesenchymal stem cells integrate functionally in an experimental animal model. Exp Eye Res. 2015;132:91–100. 10.1016/j.exer.2015.01.020 [DOI] [PubMed] [Google Scholar]
  • 34.Fernández-Pérez J, Ahearne M. Decellularization and recellularization of cornea: Progress towards a donor alternative. Methods. 2020;171:86–96. 10.1016/j.ymeth.2019.05.009 [DOI] [PubMed] [Google Scholar]
  • 35.Alió Del Barrio JL, El Zarif M, Azaar A, Makdissy N, Khalil C, Harb W, et al. Corneal Stroma Enhancement With Decellularized Stromal Laminas With or Without Stem Cell Recellularization for Advanced Keratoconus. Am J Ophthalmol. 2018;186:47–58. 10.1016/j.ajo.2017.10.026 [DOI] [PubMed] [Google Scholar]
  • 36.Da Mata Martins TM, da Silva Cunha P, Rodrigues MA, de Carvalho JL, de Souza JE, de Carvalho Oliveira JA, et al. Epithelial basement membrane of human decellularized cornea as a suitable substrate for differentiation of embryonic stem cells into corneal epithelial-like cells. Mater Sci Eng C. 2020;116:111215. 10.1016/j.msec.2020.111215 [DOI] [PubMed] [Google Scholar]
  • 37.Gueudry J, Majo F, Delcampe A, Muraine M. Panorama of limbal changes. J Fr Ophtalmol. 2019;42(3):e83–e94. 10.1016/j.jfo.2019.02.001 [DOI] [PubMed] [Google Scholar]
  • 38.Goldberg MF, Bron AJ. Limbal palisades of Vogt. Trans Am Ophthalmol Soc. 1982;80:155–171. [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Alexander V Ljubimov

29 Dec 2020

PONE-D-20-37048

Comparison of porcine corneal decellularization methods and importance of preserving corneal limbus through decellularization

PLOS ONE

Dear Dr. Ekser,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The paper has been reviewed and a number of concerns voiced. Please revise the paper and pay particular attention to the following points:

1. Please elaborate on the finding that preserving the limbus prevented structural damage and edema, but reduced the decellularization efficiency.

2. Please discuss/perform recellularization as a functional test for decellularization method that would preserve tissue architecture and ECM.

3. Please present data on evaluating epithelial removal, which is important for transplantation of recellularized cornea. The choice of decellularization method may be critical: Shafiq MA et al. 2012, Decellularized Human Cornea for Reconstructing the Corneal Epithelium and Anterior Stroma. Tissue Engineering Part C Methods 18:340.

4. Please revisit section 3.4 for discrepancy with Table 3 in relation for collagen fibril diameter changes for all decellularization methods.

5. Please better explain the data in Table 4 as suggested.

6. Please add and discuss recent papers mentioned by the reviewer and also include data on human corneas for comparison.

Please submit your revised manuscript by Feb 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Alexander V. Ljubimov, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"Work on xenotransplantation in the Xenotransplantation Research Laboratory at Indiana

University has been supported by internal funds of the Department of Surgery, in part,

with support by the Board of Directors of the Indiana University Health Values Fund for

Research Award (VFR-457-Ekser), the Indiana Clinical and Translational Sciences

Institute, funded in part by Grant # UL1TR001108 from the National Institutes of Health,

National Center for Advancing Translational Sciences, Clinical and Translational

Sciences Award, and by the special research agreement with Lung Biotechnology LLC

and United Therapeutics Corp, Silver Spring, MD, USA."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Additionally, because some of your funding information pertains to commercial funding, we ask you to provide an updated Competing Interests statement, declaring all sources of commercial funding.

In your Competing Interests statement, please confirm that your commercial funding does not alter your adherence to PLOS ONE Editorial policies and criteria by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” as detailed online in our guide for authors  http://journals.plos.org/plosone/s/competing-interests.  If this statement is not true and your adherence to PLOS policies on sharing data and materials is altered, please explain how.

Please include the updated Competing Interests Statement and Funding Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study presented appears to be an extension of the previous study that examined the same three methods of porcine cornea decellularization, along with freezing-thawing method, and that has not been referred to in this manuscript (https://cm.ixa2019.org/webapp/lecture/233). In both studies the conclusion was similar (whereas the specific data were somewhat different between the two), i.e. none of the methods tested can be considered effective and optimal. The further development of the present study is the focus on a possible role of the limbal region for the efficacy of cell removal and better preservation of the cornea.

There are some comments to consider:

1. It was found that preserving the limbus partially prevented structural damage and edema, but also reduced the decellularization efficiency. This interesting effect of the limbus should probably be discussed more than it was on p.15 (lines 1-3).

2. To find a better method of decellularization, it may be worthy to use some sort of functional test, such as evaluation of re-cellularization of decellularized porcine cornea that may depend on preservation of the tissue architecture and ECM and thus would provide ultimate criterion for developing xenotransplant.

3. No data were presented on evaluating epithelial removal which may be important for transplantation of re-cellularized cornea. From the standpoint of successful corneal cell repopulation, the choice of the cornea decellularization may be critical as shown before for human corneas (Shafiq MA et al. 2012, Decellularized Human Cornea for Reconstructing the Corneal Epithelium and Anterior Stroma. Tissue Engineering Part C Methods 18:340).

4. In Section 3.4, it appears that the data description (p.11, line 7) is incorrect, as collagen fibril diameters showed no significant changes (Table 3) for all decellularization methods.

Also, the increase of collagen fibril spacing were observed not in all groups as stated (p.11, line 9), because in “NG with limbus” group the change is not that significant (p=0.034, Table 3).

5. It is not clear how mean values in Table 4 were obtained and what did “the results in bold or italic are in favor of with limbus/ or without limbus” (p.16, l.1-3) exactly mean, so please, elaborate.

6. The list of cited literature (21 ref. long) is not full enough, and some recent papers are missing. It is probably worthwhile to also include human cornea data which are rather numerous. More specifically, promising data were reported on the use of Benzonase endonuclease alone (Liu J et al. Application of benzonase in preparation of decellularized lamellar porcine corneal stroma for lamellar keratoplasty. J. Biomed. Mater. Res. Part A 2019, 107, 2547) or Benzonase combined with SDS treatment (Alio del Barrio JL et al. 2015. Acellular human corneal matrix sheets seeded with human adipose-derived mesenchymal stem cells integrate functionally in an experimental animal model. Exp. Eye Res. 132, 91) provided minimal loss of optical transparency and good results in animal transplantation assays. Similar combined decellularization approach using sodium N-lauroyl surfactant and supernuclease resulted in good transparency and biocompatibility without degradation 4 weeks after transplantation (Dong, M. et al., Rapid porcine corneal decellularization through the use of sodium N-lauroyl glutamate and supernuclease. J. Tissue Eng. 2019, 10). Also, a recent review contained relevant corneal data (Mendibil U et al., Tissue-Specific Decellularization Methods: Rationale and Strategies to Achieve Regenerative Compounds. Int. J. Mol. Sci. 2020, 21, 5447; doi:10.3390/ijms21155447).

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 5;16(3):e0243682. doi: 10.1371/journal.pone.0243682.r002

Author response to Decision Letter 0


22 Jan 2021

RESPONSE LETTER - PONE-D-20-37048

Comparison of porcine corneal decellularization methods and importance of preserving corneal limbus through decellularization

ACADEMIC EDITOR’S COMMENTS

1. Please elaborate on the finding that preserving the limbus prevented structural damage and edema, but reduced the decellularization efficiency.

- We have now further elaborated on the impact of preserving the limbus which prevented structural damage and edema. Please see below responses to reviewers.

2. Please discuss/perform recellularization as a functional test for decellularization method that would preserve tissue architecture and ECM.

- The scope of the current manuscript is to compare decellularization methods side by side. Recellularization is not within the scope of the manuscript. However, we have further discussed possible recellularization in the discussion section. (see also below).

3. Please present data on evaluating epithelial removal, which is important for transplantation of recellularized cornea. The choice of decellularization method may be critical: Shafiq MA et al. 2012, Decellularized Human Cornea for Reconstructing the Corneal Epithelium and Anterior Stroma. Tissue Engineering Part C Methods 18:340.

- We have now further evaluated epithelial removal, as suggested. We have also added a new figure. Please see below response to the reviewer.

4. Please revisit section 3.4 for discrepancy with Table 3 in relation for collagen fibril diameter changes for all decellularization methods.

- We have now corrected this discrepancy (please see below).

5. Please better explain the data in Table 4 as suggested.

- Please see below – response to the reviewer.

6. Please add and discuss recent papers mentioned by the reviewer and also include data on human corneas for comparison.

- We have now added all suggested papers.

Reviewer #1: The study presented appears to be an extension of the previous study that examined the same three methods of porcine cornea decellularization, along with freezing-thawing method, and that has not been referred to in this manuscript (https://cm.ixa2019.org/webapp/lecture/233).

- We thank the reviewer for her/his comments. The link belongs to OUR initial observation which was presented at the International Xenotransplantation Association Meeting as an abstract.

In both studies the conclusion was similar (whereas the specific data were somewhat different between the two), i.e. none of the methods tested can be considered effective and optimal. The further development of the present study is the focus on a possible role of the limbal region for the efficacy of cell removal and better preservation of the cornea.

- As noted by the reviewer, the link belongs to an abstract where only OUR initial observations were presented. We have further analyzed and increased the ‘n’ to write the current manuscript. In fact, the reviewer also noted that in the abstract there was no information regarding limbus since that was a research in progress and we have presented our complete data in the current manuscript.

1. It was found that preserving the limbus partially prevented structural damage and edema, but also reduced the decellularization efficiency. This interesting effect of the limbus should probably be discussed more than it was on page 15 (lines 1-3).

- We have now extended the “Importance of corneoscleral limbus” section by further discussing the results of Table 4 in details. We have specifically added/changed below comments in regarded section.

“According to our results, ultrastructural parameters including thickness after decellularization, thickness after glycerol treatment, and collagen fibril spacing were significantly different between the groups with and without limbus, favoring the group with limbus. However, another structural parameter, collagen fibril diameter, did not show statistically significant change despite the preservation of limbus (Table 3). The decellularization parameter, amount of nucleic acid, was significantly different in the group without limbus in SDS- and HS-based methods but not in NG-based method. Our results indicate that preserving the corneoscleral limbus partially prevented structural damage and edema but would reduce the decellularization capacity (except NG). These differences may originate from the unique structure of the corneoscleral limbus that partly prevents decellularization agents to permeate into the tissue.”

2. To find a better method of decellularization, it may be worthy to use some sort of functional test, such as evaluation of re-cellularization of decellularized porcine cornea that may depend on preservation of the tissue architecture and ECM and thus would provide ultimate criterion for developing xenotransplant.

- We agree with the reviewer that re-cellularization of decellularized porcine cornea may be a test to further evaluate the functionality. The scope of the current manuscript is to compare side-by-side 3 decellularization techniques with or without limbus (which was never done before). Evaluating re-epithelialization, stromal re-cellularization and re-endothelialization between with limbus and without limbus groups are of our interests and definitely among our future plans. However, due to our current situation and strict limitation in basic science research due to COVID-19 at academic institutes, we will not be able to perform recellularization experiments for foreseeable future.

- Because of the importance and up-to-date-ness of the matter, we have now added the below paragraph to the discussion section where we have further discussed recellularization and possible effects of preserving limbus on recellularization with recent publications.

“After obtaining a decellularized porcine corneal matrix, the ultimate goal is to recellularize it with human cells. Several different cell types (adipose stem cells, induced pluripotent stem cells, keratocytes, endothelial cells, embryonic stem cells) and various recellularization techniques (seeding, injection) have been used for repopulation of human corneal cells. Previously, SDS, HS, and NG based methods created a decellularized cornea that is suitable for recellularization. Future studies will focus on the effect of preserving limbus on recellularization.”

3. No data were presented on evaluating epithelial removal which may be important for transplantation of re-cellularized cornea. From the standpoint of successful corneal cell repopulation, the choice of the cornea decellularization may be critical as shown before for human corneas (Shafiq MA et al. 2012, Decellularized Human Cornea for Reconstructing the Corneal Epithelium and Anterior Stroma. Tissue Engineering Part C Methods 18:340).

- We thank the reviewer for her/his comments. We agree with the reviewer that it is an important point. In order to evaluate the epithelial removal, we have now further analyzed the decellularized epitheliums in all three decellularization methods (SDS, HS, NG) with or without limbus. We have now added a new figure (Figure 3) and new results have been added to the result section on page 8.

4. In Section 3.4, it appears that the data description (p.11, line 7) is incorrect, as collagen fibril diameters showed no significant changes (Table 3) for all decellularization methods.

- We thank the reviewer for this observation. We have now omitted the part of “resulting in a loss of fibrils” and then re-wrote the sentence as below.

“SDS disrupted the ultrastructure of the cornea most severely, resulting in disorganization of fibrils, and therefore increased spacing between the fibrils in corneas both with and without limbus.”

Also, the increase of collagen fibril spacing were observed not in all groups as stated (p.11, line 9), because in “NG with limbus” group the change is not that significant (p=0.034, Table 3).

- We have considered p value <0.05 is a statistically significant finding. Therefore, abovementioned p value (p=0.034) was a statistically significant finding for us. We apologize but we did not understand the reviewer’s comment on “not that significant”.

5. It is not clear how mean values in Table 4 were obtained and what did “the results in bold or italic are in favor of with limbus/ or without limbus” (p.16, l.1-3) exactly mean, so please, elaborate.

- We thank to the reviewer for pointing out the ambiguity in Table 4. We have now improved and elaborated the meaning of Table 4 by adding further explanation in the legend. We have also mentioned where we obtained the mean values in the first column of the table.

“More decellularization and better preservation of corneal structure considered as favorable. (In this table each p value represents the comparison of the mean values of decellularized corneas with limbus vs without limbus in respected parameter and method. For example, in the first box, p=0.0022 represents the comparison of thickness after decellularization between SDS with limbus and SDS without limbus group.)”

6. The list of cited literature (21 ref. long) is not full enough, and some recent papers are missing. It is probably worthwhile to also include human cornea data which are rather numerous. More specifically, promising data were reported on the use of Benzonase endonuclease alone (Liu J et al. Application of benzonase in preparation of decellularized lamellar porcine corneal stroma for lamellar keratoplasty. J. Biomed. Mater. Res. Part A 2019, 107, 2547) or Benzonase combined with SDS treatment (Alio del Barrio JL et al. 2015. Acellular human corneal matrix sheets seeded with human adipose-derived mesenchymal stem cells integrate functionally in an experimental animal model. Exp. Eye Res. 132, 91) provided minimal loss of optical transparency and good results in animal transplantation assays. Similar combined decellularization approach using sodium N-lauroyl surfactant and supernuclease resulted in good transparency and biocompatibility without degradation 4 weeks after transplantation (Dong, M. et al., Rapid porcine corneal decellularization through the use of sodium N-lauroyl glutamate and supernuclease. J. Tissue Eng. 2019, 10). Also, a recent review contained relevant corneal data (Mendibil U et al., Tissue-Specific Decellularization Methods: Rationale and Strategies to Achieve Regenerative Compounds. Int. J. Mol. Sci. 2020, 21, 5447; doi:10.3390/ijms21155447).

- We thank to the reviewer for suggesting up-to-date papers for our article. We have now added all suggested papers as well as couple more from 2019 and 2020. Below please find the new references.

12 - Mendibil U, Ruiz-Hernandez R, Retegi-Carrion S, Garcia-Urquia N, Olalde-Graells B, Abarrategi A. Tissue-Specific Decellularization Methods: Rationale and Strategies to Achieve Regenerative Compounds. Int J Mol Sci. 2020;21(15):5447.

13 - Sasaki S, Funamoto S, Hashimoto Y, Kimura T, Honda T, Hattori S, et al. In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas. Mol Vis. 2009;15:2022-2028.

14 - Topuz B, Günal G, Guler S, Aydin HM. Use of supercritical CO2 in soft tissue decellularization. Methods Cell Biol. 2020;157:49-79.

15 - Wu Z, Zhou Y, Li N, Huang M, Duan H, Ge J, et al. The use of phospholipase A(2) to prepare acellular porcine corneal stroma as a tissue engineering scaffold. Biomaterials. 2009;30(21):3513-22.

16 - Lin HJ, Wang TJ, Li TW, Chang YY, Sheu MT, Huang YY, et al. Development of Decellularized Cornea by Organic Acid Treatment for Corneal Regeneration. Tissue Eng Part A. 2019;25(7-8):652-662.

17 - Liu J, Li Z, Li J, Liu Z. Application of benzonase in preparation of decellularized lamellar porcine corneal stroma for lamellar keratoplasty. J Biomed Mater Res A. 2019;107(11):2547-2555.

18 - Dong M, Zhao L, Wang F, Hu X, Li H, Liu T, et al. Rapid porcine corneal decellularization through the use of sodium N-lauroyl glutamate and supernuclease. J Tissue Eng. 2019;10:2041731419875876.

22 - Shafiq MA, Gemeinhart RA, Yue BY, Djalilian AR. Decellularized human cornea for reconstructing the corneal epithelium and anterior stroma. Tissue Eng Part C Methods. 2012;18(5):340-8.

33 - Alio del Barrio JL, Chiesa M, Garagorri N, Garcia-Urquia N, Fernandez-Delgado J, Bataille L, et al. Acellular human corneal matrix sheets seeded with human adipose-derived mesenchymal stem cells integrate functionally in an experimental animal model. Exp Eye Res. 2015;132:91-100.

34 - Fernández-Pérez J, Ahearne M. Decellularization and recellularization of cornea: Progress towards a donor alternative. Methods. 2020;171:86-96.

35 - Alió Del Barrio JL, El Zarif M, Azaar A, Makdissy N, Khalil C, Harb W, et al. Corneal Stroma Enhancement With Decellularized Stromal Laminas With or Without Stem Cell Recellularization for Advanced Keratoconus. Am J Ophthalmol. 2018;186:47-58.

36 - Da Mata Martins TM, da Silva Cunha P, Rodrigues MA, de Carvalho JL, de Souza JE, de Carvalho Oliveira JA, et al. Epithelial basement membrane of human decellularized cornea as a suitable substrate for differentiation of embryonic stem cells into corneal epithelial-like cells. Mater Sci Eng C. 2020;116:111215.

We thank the editors and reviewers for their positive comments, questions, and feedbacks. We believe that the revised version is now much better than the original submission with their inputs. We hope that the revised version is now acceptable for publication.

Yours sincerely,

Abdulkadir Isidan, MD

Burcin Ekser, MD, PhD

(on behalf of all coauthors).

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Alexander V Ljubimov

3 Feb 2021

Comparison of porcine corneal decellularization methods and importance of preserving corneal limbus through decellularization

PONE-D-20-37048R1

Dear Dr. Ekser,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Alexander V. Ljubimov, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Alexander V Ljubimov

23 Feb 2021

PONE-D-20-37048R1

Comparison of porcine corneal decellularization methods and importance of preserving corneal limbus through decellularization

Dear Dr. Ekser:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Alexander V. Ljubimov

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (XLSX)

    S2 Data

    (XLSX)

    S3 Data

    (XLSX)

    S4 Data

    (XLSX)

    S5 Data

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES